A High-Confidence Human Plasma Proteome Reference Set with Estimated Concentrations in PeptideAtlas

Abstract

Human blood plasma can be obtained relatively noninvasively and contains proteins from most, if not all, tissues of the body. Therefore, an extensive, quantitative catalog of plasma proteins is an important starting point for the discovery of disease biomarkers. In 2005, we showed that different proteomics measurements using different sample preparation and analysis techniques identify significantly different sets of proteins, and that a comprehensive plasma proteome can be compiled only by combining data from many different experiments. Applying advanced computational methods developed for the analysis and integration of very large and diverse data sets generated by tandem MS measurements of tryptic peptides, we have now compiled a high-confidence human plasma proteome reference set with well over twice the identified proteins of previous high-confidence sets. It includes a hierarchy of protein identifications at different levels of redundancy following a clearly defined scheme, which we propose as a standard that can be applied to any proteomics data set to facilitate cross-proteome analyses. Further, to aid in development of blood-based diagnostics using techniques such as selected reaction monitoring, we provide a rough estimate of protein concentrations using spectral counting. We identified 20,433 distinct peptides, from which we inferred a highly nonredundant set of 1929 protein sequences at a false discovery rate of 1%. We have made this resource available via PeptideAtlas, a large, multiorganism, publicly accessible compendium of peptides identified in tandem MS experiments conducted by laboratories around the world. Molecular & Cellular

Cell type-specific genes show striking and distinct patterns of spatial expression in the mouse brain

“…Cross-referencing these lists with lists of proteins previously reported as being present in the blood of healthy individuals (19) revealed that 29 neuron-specific genes were present in blood; 13 of these were brain-specific as well (Dataset S3). We believe that concentrations of the brain-specific blood proteins could change during disease or injury (presumably reflecting the activity of disease-perturbed biological networks), or that disease or injury could cause brain-specific proteins not normally found in the blood to be secreted.…”

Inference and Validation of Protein Identifications

“…Latter approaches might miss protein identifications that are falsely discarded by the a priori grouping scheme or the parsimony constraint. Instead of disambiguating ambiguous peptide identifications, Farrah et al report all proteins consistent with the spectral data (42). To be able to make statements about the occurrence of proteins in the biological sample, the authors of this study introduced the CEDAR scheme for protein identifications.…”

“…In this analogy the first type of balls represents the protein entries for which there is correct support and the other type represents all other entries of the underlying protein database. Mayu has shown to achieve accurate, independently validated protein identification false discovery rates for a range of diverse datasets differing in size, underlying proteome and experimental setting (53) and been added as additional feature to PeptideAtlas (42).…”

Different fractions of human serum glycoproteins bind galectin-1 or galectin-8, and their ratio may provide a refined biomarker for pathophysiological conditions in cancer and inflammatory disease

“…For 2-aminobenzoic acid (AA) labeling, the dried, purified glycan samples were dissolved in 50 μl water and mixed with 25 μl of a freshly prepared label solution (48 mg/ml AA in DMSO containing 15% glacial acetic acid) (29). Twenty-five μl aliquots of freshly prepared reducing agent solution (1 M 2-picoline borane in DMSO) were added, followed by 10 min of Carlsson et al,page 8 shaking and incubation at 65°C for 2h.…”